# SWS And Daytime Functioning in Chronic FatiguE Syndrome (SAFFE)

> **NCT02055898** · PHASE4 · COMPLETED · sponsor: **Imperial College London** · enrollment: 13 (actual)

## Conditions studied

- Chronic Fatigue Syndrome

## Interventions

- **DRUG:** Sodium Oxybate
- **OTHER:** placebo (fresh potable water)

## Key facts

- **NCT ID:** NCT02055898
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2020-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055898, "SWS And Daytime Functioning in Chronic FatiguE Syndrome (SAFFE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02055898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*